{"brief_title": "A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke", "brief_summary": "The purpose of this study is to determine whether a new research medication is effective and safe for the treatment of acute stroke when given within 6 hours of the onset of stroke.", "condition": ["Stroke"], "intervention_type": ["Drug"], "intervention_name": ["traxiprodil (CP-101,606)"], "criteria": "Inclusion Criteria: Males & females age 40-90 years Enrolled in study within 6 hours of onset of stroke symptoms Willing to sign informed consent form No significant disabilities prior to stroke Exclusion Criteria: Treatment with t-PA (tissue plasminogen activator) Premorbid modified rankin scale score of 2 or more", "gender": "All", "minimum_age": "40 Years", "maximum_age": "90 Years", "healthy_volunteers": "No", "mesh_term": ["Stroke"], "id": "NCT00073476"}